Current understanding of the mechanisms involved in metabolic detoxification of warfare nerve agents

Toxicology Letters

Volumn 188, Issue 1, 2009, Pages 1-10

  Jokanović, Milan ^a,b  

^a Experta Consulting   (Serbia)

^b Academy of Sciences and Arts of Republic Srpska   (Bosnia and Herzegovina)

Author keywords

Nerve agents; Organophosphorus; Sarin; Soman; Tabun; VX

Indexed keywords

ACETYLCHOLINESTERASE; ALBUMIN; ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; ATROPINE; CARBOXYLESTERASE; DIAZEPAM; DYFLOS; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; ORGANOPHOSPHORUS COMPOUND; OXIME; SARIN; SOMAN; TABUN;

BIOLOGICAL WARFARE; BIOTRANSFORMATION; CHOLINESTERASE BLOOD LEVEL; DETOXIFICATION; ENZYME ACTIVITY; HUMAN; INTOXICATION; METABOLISM; METABOLITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW;

ADIPOSE TISSUE; ANIMALS; CARBOXYLESTERASE; CHEMICAL WARFARE AGENTS; CHOLINESTERASES; ESTERASES; HUMANS; HYDROLYSIS; METABOLIC DETOXICATION, DRUG; ORGANOPHOSPHORUS COMPOUNDS; PROTEIN BINDING; SERUM ALBUMIN; TISSUE DISTRIBUTION;

EID: 67349251505     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2009.03.017     Document Type: Review

References (99)

1. Aldridge W.N. Serum esterases. I. Two types of esterases (A and B) hydrolysing p-nitrophenyl acetate, propionate, butyrate and a method for their determination. Biochem. J. 53 (1953) 110-117
2. Ashani Y., Rothschild N., Segall Y., Levanon D., and Raveh L. Prophylaxis against organophosphate poisoning by an enzyme hydrolysing organophosphorus compounds in mice. Life Sci. 49 (1991) 367-374
3. Ashani Y., Shapira S., Levy D., Wolfe A.D., Doctor B.P., and Raveh L. Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. Biochem. Pharmacol. 41 (1991) 37-41
4. Aviram M., Rosenblat M., Bisgaier C.L., Newton R.S., Primo-Parmo S.L., and La Du B.N. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its function. J. Clin. Invest. 101 (1998) 1581-1590
5. Augustinsson K.B. Electrophoretic separation and classification of blood plasma esterases. Nature 131 (1958) 1786-1789
6. Barril J., Estevez J., Escudero M.A., Cespedes M.V., Niguez N., Sogorb M.A., Monroy A., and Vilanova E. Peripheral nerve soluble esterases are spontaneously reactivated after inhibition by paraoxon: implications for a new definition of neuropathy target esterase. Chem. Biol. Interact. 119-120 (1999) 541-550
7. Benning M.M., Kuo J.M., Raushel F.M., and Holden H.M. Three-dimensional structure of phosphotriesterase: an enzyme capable of detoxifying organophosphate nerve agents. Biochemistry 33 (1994) 15001-15007
8. Benschop H.P., and De Jong L.P.A. Toxicokinetics of soman: species variation and stereospecificity in elimination pathways. Neurosci. Biobehav. Rev. 15 (1991) 73-77
9. Benschop, H.P., van der Schans, M.J., Langenberg, J.P., 2000. Toxicokinetics of O-ethyl S-(2-diisopropylaminoethyl)methylphosphonothioate [(±)-VX] in rats, hairless guinea pigs and marmosets-identification of metabolic pathways. Cited in: Acute Exposure Guideline Levels for Selected Airborne Chemicals, vol. 3. The National Academies Press, Washington DC, 2003, pp. 122.
10. Bird S.B., Sutherland T.D., Gresham C., Oakeshott J., Scott C., and Eddleston M. OpdA, a bacterial organophosphorus hydrolase, prevents lethality in rats after poisoning with highly toxic organophosphorus pesticides. Toxicology 247 (2008) 88-92
11. Bošković B. The Influence of 2-(o-cresyl)-4 H-1:3:2-benzodioxa-phosphorin-2-oxide (CBDP) on organophosphate poisoning and its therapy. Arch. Toxicol. 42 (1978) 207-216
12. Bošković B., Jokanović M., and Maksimović M. Effects of sarin, soman and tabun on plasma and brain aliesterase activity in the rat. In: Brzin M., Barnard E.A., and Sket D. (Eds). Cholinesterases-Fundamental and Applied Aspects (1984), Walter de Gruyter, Berlin, New York 365-374
13. Brealey C.J., Walker C.H., and Baldwin B.C. 'A'-esterase activity in relation to the differential toxicity of pirimiphos-methyl to birds and mammals. Pestic. Sci. 11 (1980) 546-554
14. Casida J.E., and Quistad G.B. Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets. Chem. Res. Toxicol. 17 (2004) 983-998
15. Cashman J.R., Perotti B.Y.T., Berkman C.E., and Lin J. Pharmacokinetics and molecular detoxication. Environ. Health Perspect. 104 Suppl 1 (1996) 23-40
16. Chambers J.E., Carr R.L., Boone J.S., and Chambers H.W. The metabolism of organophosphorus insecticides. In: Krieger R.I. (Ed). Handbook of Pesticide Toxicology-Agents. 2nd ed. (2001), Academic Press, San Diego 919-928
17. Chanda S.M., Lassiter T.L., Moser V.C., Barone Jr. S., and Padilla S. Tissue carboxylesterases and chlorpyrifos toxicity in the developing rat. Hum. Ecol. Risk Assess. 8 (2002) 75-90
18. Clement J.G. Role of aliesterase in organophosphate poisoning. Fundam. Appl. Toxicol. 4 (1984) S96-S105
19. Costa L.G., McDonald B.E., Murphy S.D., Omenn G.S., Richter R.J., Motulsky A.G., and Furlong C.E. Serum paraoxonase and its influence on paraoxon and chlorpyriphos-oxon toxicity in rats. Toxicol. Appl. Pharmacol. 103 (1990) 66-76
20. Costa L.G., Li W.F., Richter R.J., Shih D.M., Lusis A., and Furlong C.E. The role of paraoxonase (PON1) in the detoxification of organophosphates and its human polymorphism. Chem.-Biol. Interact. 119-120 (1999) 429-438
21. Costa L.G., Cole T.B., Jarvik G.P., and Furlong C.E. Functional genomics of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annu. Rev. Med. 54 (2003) 371-392
22. Costa L.G., Cole T.B., Vitalone A., and Furlong C.E. Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity. Clin. Chim. Acta 352 (2005) 37-47
23. Costa L.G., Cole T.B., Vitalone A., and Furlong C.E. Paraoxonase polymorphisms and toxicity of organophosphates. In: Gupta R.C. (Ed). Toxicology of organophosphate and carbamate compounds (2006), Elsevier, Inc., Amsterdam 247-255 (Chapter 18)
24. Davies J.E., Barquet A., Freed V.H., Hague R., Morgade C., Sonneborn R.E., and Vaclavek C. Human pesticide poisonings by a fat-soluble organophosphate insecticide. Arch. Environ. Health 30 (1975) 608-613
25. Dettbarn W.-D., Yang Z.P., and Milatović D. Different role of carboxylesterases in toxicity and tolerance to paraoxon and DFP. Chem.-Biol. Interact. 119-120 (1999) 445-454
26. Doctor B.P., Maxwell D.M., Ashani Y., Saxena A., and Gordon R.K. New approaches to medical protection against chemical warfare nerve agents. In: Somani S.M., and Romano J.A. (Eds). Chemical Warfare Agents: Toxicity at Low Levels (2001), CRC Press, Boca Raton 191-212 (Chapter 6)
27. Ecobichon D.J., Ozere R.L., Reid E., and Crocker J.E. Acute fenitrothion poisoning. Can. Med. Assoc. J. 116 (1977) 377-379
28. Eto M., Casida J.E., and Eto T. Hydroxylation of cyclization reactions involved in the metabolism of tri-o-cresyl phosphate. Biochem. Pharmacol. 11 (1962) 337-352
29. Eyer P. The role of oximes in the management of organophosphorus pesticide poisoning. Toxicol. Rev. 22 (2003) 165-190
30. Fonnum F., and Sterri S.H. Factors modifying the toxicity of organophosphorus compounds including soman and sarin. Fundam. Appl. Toxicol. 1 (1981) 143-147
31. Frawley J.P., Fuyat H.N., Hagan E.C., Blake J.R., and Fitzhugh O.G. Marked potentiation of mammalian toxicity from simultaneous administration of two anticholinesterase compounds. J. Pharmacol. Exp. Ther. 121 (1957) 96-106
32. Fukuto T.R. Mechanism of action of organophosphorus and carbamate insecticides. Environ. Health Perspect. 87 (1990) 245-254
33. Furlong C.E. PON1 status and neurologic symptom complexes in Gulf War veterans. Genome Res. 10 (2000) 153-155
34. Furlong C.E., Li W.F., Brophy V.H., Jarvik G.P., Richter R.J., Shih D.M., Lusis A.J., and Costa L.G. The PON1 gene and detoxication. Neurotoxicology 21 (2000) 581-587
35. Gupta R.C., Patterson G.T., and Dettbarn W.-D. Biochemical and histochemical alterations following acute soman intoxication in the rat. Toxicol. Appl. Pharmacol. 87 (1987) 393-402
36. Gupta R.C., Patterson G.T., and Dettbarn W.-D. Acute tabun toxicity: biochemical and histochemical consequences in brain and skeletal muscles of rat. Toxicology 46 (1987) 329-341
37. Haley R.W., Billecke S., and La Du B.N. Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. Toxicol. Appl. Pharmacol. 157 (1999) 227-233
38. Hernandez A., Gomez M.A., Pena G., Gil F., Rodrigo L., Villanueva E., and Pla A. Effect of long-term exposure to pesticides on plasma esterases from plastic greenhouse workers. J. Toxicol. Environ. Health A 67 (2004) 1095-1108
39. Hosokawa M., and Satoh T. Structure, function, and regulation of carboxylesterases. In: Gupta R.C. (Ed). Toxicology of Organophosphate and Carbamate Compounds (2006), Elsevier, Inc., Amsterdam 219-231 Chapter 16
40. International Union of Biochemistry. Enzyme Nomenclature. Recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the Nomenclature and Classification of Enzymes (1992), Academic Press, Inc., San Diego
41. Jokanović M. Role of carboxylesterase in soman, sarin and tabun poisoning in rats. Pharmacol. Toxicol. 65 (1989) 181-184
42. Jokanović M. Liver esterases and soman toxicity in the rat following partial hepatectomy. Biochem. Pharmacol. 39 (1990) 797-799
43. Jokanović M., and Maksimović M. Abnormal cholinesterase activity:understanding and interpretation. Eur. J. Clin. Chem. Clin. Biochem. 35 (1997) 11-16
44. Jokanović M., Kosanović M., and Maksimović M. Interaction of organophosphorus compounds with carboxylesterases in the rat. Arch. Toxicol. 70 (1996) 444-450
45. Jokanović M. Biotransformation of organophosphorus compounds. Toxicology 166 (2001) 139-160
46. 3H-soman in mice. Arch. Toxicol. 58 (1985) 45-49
47. Kaliste-Korhonen E., Tuovinen K., and Hanninen O. Interspecies differences in enzymes reacting with organophosphates and their inhibition by paraoxon in vitro. Hum. Exp. Toxicol. 15 (1996) 972-978
48. La Du B.N., Adkins S., Kuo C.L., and Lipsig D. Studies on human serum paraoxonase/arylesterase. Chem.-Biol. Interact. 87 (1993) 25-34
49. La Du B.N., Billecke S., Hsu C., Haley R.W., and Broomfield C.A. Serum paraoxonase (PON1) isoenzymes: the quantitative analysis of isoenzymes affecting individual sensitivity to environmental chemicals. Drug Metab. Dispos. 29 (2001) 566-569
50. Lauwerys R.R., and Murphy S.D. Interaction between paraoxon and tri-o-tolyl phosphate in rats. Toxicol. Appl. Pharmacol. 14 (1969) 348-357
51. Li W.F., Costa L.G., and Furlong C.E. Serum paraoxonase status: a major factor in determining resistance to organophosphates. J. Toxicol. Environ. Health 40 (1993) 337-346
52. Li W.F., Furlong C.E., and Costa L.G. Paraoxonase protects against chlorpyrifos toxicity in mice. Toxicol. Lett. 76 (1995) 219-226
53. Li W.S., Lum K.T., Chen-Goodspeed M., Sogorb M.A., and Raushel F.M. Stereoselective detoxification of chiral sarin and soman analogs by phosphotriesterase. Bioorg. Med. Chem. 9 8 (2001) 2083-2091
54. Li B., Sedlacek M., Manoharan I., Boopathy R., Duysen E.G., Masson P., and Lockridge O. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem. Pharmacol. 70 (2005) 1673-1684
55. Li B., Schopfer L.M., Hinrichs S.H., Masson P., and Lockridge O. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay for organophosphorus toxicants bound to human albumin at Tyr411. Anal. Biochem. 361 (2007) 263-272
56. Li B., Nachon F., Froment M.-T., Verdier L., Debouzy J.-C., Brasme B., Gillon E., Schopfer L.M., Lockridge O., and Masson P. Binding and hydrolysis of soman by human serum albumin. Chem. Res. Toxicol. 21 (2008) 421-431
57. 3H sarin and its metabolites in mice. Toxicol. Appl. Pharmacol. 83 (1986) 412-419
58. Mackness M.I. 'A'-esterases: enzymes looking for a role?. Biochem. Pharmacol. 38 (1989) 385-390
59. Mackness M.I., Arrol S., Abbott C.A., and Durrington P.N. Is paraoxonase related to atherosclerosis. Chem.-Biol. Interact. 87 (1993) 161-171
60. Mackness B., Durrington P.N., and Mackness M.I. Low paraoxonase in Persian Gulf War veterans self-reporting Gulf War syndrome. Biochem. Biophys. Res. Commun. 276 (2000) 729-733
61. Main A.R. The role of A-esterase in the acute toxicity of paraoxon, TEPP and parathion. Can. J. Biochem. Physiol. 34 (1956) 197-216
62. Maxwell D.M. The specificity of carboxylesterase protection against the toxicity of organophosphorus compounds. Toxicol. Appl. Pharmacol. 114 (1992) 306-312
63. Maxwell D.M., Brecht K., Saxena A., Feaster S., and Doctor B.P. Comparison of cholinesterases and carboxylesterases as bioscavangers of organophosphorus compounds. In: Doctor B.P., Taylor P., Quinn D.M., Rotundo R.L., and Gentry M.K. (Eds). Structure and Function of Cholinesterases and Related Proteins (1998), Springer 387-393
64. Murphy S.D., Anderson R.L., and DuBois K.P. Potentiation of toxicity of malathion by triorthotolyl phosphate. Proc. Soc. Exp. Biol. Med. 100 (1959) 382-487
65. Minami M., Hui D.M., Katsumata M., Inagaki H., and Boulet C.A. Method for the analysis of the methylphosphonic acid metabolites of sarin and its ethanol-substituted analogue in urine as applied to the victims of the Tokyo sarin disaster. J. Chromatogr. B: Biomed. Sci. Appl. 695 (1997) 237-244
66. Minami M., Hui D.M., Wang Z., Katsumata M., Inagaki H., Li Q., Inuzuka S., Mashiko K., Yamamoto Y., Ootsuka T., Boulet C.A., and Clement J.G. Biological monitoring of metabolites of sarin and its by-products in human urine samples. J. Toxicol. Sci. 23 Suppl. 2 (1998) 250-254
67. Munger J.S., Shi G.-P., Mark E.A., Chin D.T., Gerard C., and Chapman H.A. A serine esterase released by human alveolar macrophages is closely related to liver microsomal carboxylesterases. J. Biol. Chem. 266 (1991) 18832-18838
68. Munro N.B., Talmage S.S., Griffin G.D., Waters L.C., Watson A.P., King J.F., and Hauschild V. The sources, fate, and toxicity of chemical warfare agent degradation products. Environ. Health Perspect. 107 (1999) 933-974
69. Nakajima T., Sasaki K., Ozawa H., Sekijima Y., Morita H., Fukushima Y., and Yanagisawa N. Urinary metabolites of sarin in a patient of the Matsumoto sarin incident. Arch. Toxicol. 72 (1998) 601-603
70. Noort D., Hulst A.G., Platenburg D.H.J.M., Polhuijs M., and Benschop H.P. Quantitative analysis of O-isopropyl methylphosphonic acid in serum samples of Japanese citizens allegedly exposed to sarin: estimation of internal dosage. Arch. Toxicol. 72 (1998) 671-675
71. Noort D., Benschop H.P., and Black R.M. Biomonitoring of exposure to chemical warfare agents: a review. Toxicol. Appl. Pharmacol. 184 (2002) 116-126
72. Reiner E., and Pleština R. Regeneration of cholinesterase activities in humans and rats after inhibition by O,O-dimethyl-2,2-dichlorvinyl phosphate. Toxicol. Appl. Pharmacol. 49 (1979) 451-454
73. Raveh L., Grauer E., Grunwald J., Cohen E., and Ashani Y. The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase. Toxicol. Appl. Pharmacol. 145 (1997) 43-53
74. Rochu D., Chabriere E., and Masson P. Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning. Toxicology 233 (2007) 47-59
75. Satoh T., and Hosokawa M. The mammalian carboxylesterases: from molecules to functions. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 257-288
76. Saxena A., Redman A.M.G., Jiang X., Lockridge O., and Doctor B.P. Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase. Chem.-Biol. Interact. 119-120 (1999) 61-69
77. Shih M.L., McMonagle J.D., and Dolzine W. Metabolite pharmacokinetics of soman, sarin and GF in rats and biological monitoring of exposure to toxic organophosphorus agents. J. Appl. Toxicol. 14 (1994) 195-199
78. Sogorb M.A., Sellero I., López Rivadulla M., Céspedes V., and Vilanova E. EDTA-resistant and sensitive phosphotriesterase activities associated with albumin and lipoproteins in rabbit serum. Drug Metab. Dispos. 27 (1999) 53-59
79. Sogorb M.A., Vilanova E., and Carrera V. Future applications of phosphotriesterases in the prophylaxis and treatment of organophosphorus insecticide and nerve agent poisonings. Toxicol. Lett. 151 (2004) 219-233
80. Sogorb M.A., García-Argüelles S., Carrera V., and Vilanova E. Serum albumin is as efficient as paraxonase in the detoxication of paraoxon at toxicological relevant concentrations. Chem. Res. Toxicol. 21 (2008) 1524-1529
81. Sogorb M.A., Carrera V., Quesada E., Sabater E., and Vilanova E. Characterization of the paraoxonase-like activity associated to human serum albumin. Toxicol. Lett. 172 Suppl. 1 (2007) S237
82. Somani S.M., Solana R.P., and Dube S.N. Toxicodynamics of nerve agents. In: Somani S.M. (Ed). Chemical Warfare Agents (1992), Academic Press, Inc., New York 67-123
83. Stevens R.C., Suzuki S.M., Cole T.B., Park S.S., Richter R.J., and Furlong C.E. Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning. Proc. Natl. Acad. Sci. U.S.A. 105 35 (2008) 12780-12784
84. Tang J., Rose R.L., and Chambers J.E. Metabolism of organophosphorus and carbamate pesticides. In: Gupta R.C. (Ed). Toxicology of Organophosphate and Carbamate Compounds (2006), Elsevier, Inc., Amsterdam 127-143 (Chapter 10)
85. Tarhoni M.H., Lister T., Ray D.E., and Carter W.G. Albumin binding as a potential biomarker of exposure to moderately low levels of organophosphorus pesticides. Biomarkers 13 (2008) 343-363
86. Tsuchihashi H., Katagi M., Nishikawa M., and Tatsuno M. Identification of metabolites of nerve agent VX in serum collected from a victim. J. Anal. Toxicol. 22 (1998) 383-388
87. Tuovinen K., Kaliste-Korhonen E., Raushel F.M., and Hänninen O. Phosphotriesterase-a promising candidate for use in detoxication of organophosphate. Fundam. Appl. Toxicol. 23 (1994) 578-584
88. van der Schans M.J., Lander B.J., van der Wiel H., Langenberg J.P., and Benschop H.P. Toxicokinetics of the nerve agent (±)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration. Toxicol. Appl. Pharmacol. 191 (2003) 48-62
89. van der Schans M.J., Benschop H.P., and Whalley C.E. Toxicokinetics of nerve agents. In: Romano Jr. J.A., Lukey B.J., and Salem H. (Eds). Chemical Nerve Agents: Chemistry, Pharmacology, Toxicology, and Therapeutics. 2nd ed. (2007), CRC Press (Chapter 5)
90. Van Dongen C.J., Van Helden H.P., and Wolthuis O.L. Further evidence for the effect of pinacolyl dimethylphosphinate on soman storage in muscle tissue. Eur. J. Pharmacol. 127 (1986) 135-138
91. Van Helden H.P., and Wolthuis O.L. Evidence for an intramuscular depot of the cholinesterase inhibitor soman in the rat. Eur. J. Pharmacol. 89 (1983) 271-274
92. Vilanova E., and Sogorb M.A. The role of phosphotriesterases in the detoxication of organophosphorus compounds. Crit. Rev. Toxicol. 29 (1999) 21-57
93. Vitarius J.A., and Sultatos L.G. The role of calcium in hydrolysis of the organophosphate paraoxon by human serum A-esterase. Life Sci. 56 (1995) 125-134
94. Walker C.H., and Mackness M.I. "A" esterases and their role in regulating the toxicity of organophosphates. Arch. Toxicol. 60 (1987) 30-33
95. Walker C.H. The classification of esterases which hydrolyse organophosphates: recent developments. Chem.-Biol. Interact. 87 (1993) 17-24
96. Williams N.H., Harrison J.M., Read R.W., and Black R.M. Phosphylated tyrosine in albumin as a biomarker of exposure to organophosphorus nerve agents. Arch. Toxicol. 81 (2007) 627-639
97. World Health Organization, 1986. Organophosphorus insecticides: a general introduction. Environmental Health Criteria 63, Geneva.
98. Yamada Y., Takatori T., Nagao M., Iwase H., Kuroda N., Yanagida J., and Shinozuka T. Expression of paraoxonase isoform did not confer protection from acute sarin poisoning in the Tokyo subway terrorist attack. Int. J. Legal. Med. 115 (2001) 82-84
99. Yamasaki Y., Sakamoto K., Watada H., Kajimoto Y., and Hori M. The Arg 192 isoform of paraoxonase with low sarin-hyrolyzing activity is dominant in the Japanese. Japan. Hum. Genet. 10 (1997) 67-68